Real Chemistry and WhizAI Debut Generative AI-Based Patient Journey Visualization and Analytics Solution

Solution provides accurate and contextual insights for better patient outcomes

Real Chemistry, a leading provider of AI-driven insights and marketing and communications for the healthcare industry, announced a strategic partnership with WhizAI, a leading AI-powered analytics platform purpose-built for life sciences and healthcare. The companies will collaborate on a dynamic patient journey visualization and analytics solution that leverages Real Chemistry’s robust AI and analytics engines. The new offering will make it easy for clients to access accurate, contextual insights and visualize the process patients go through from diagnosis to treatment to better understand access, affordability and adherence to treatments.

AiThority Interview Insights: How to Get Started with Prompt Engineering in Generative AI Projects

“Real Chemistry is a leader in uncovering insights for complex diseases and mapping treatments by using vast amounts of patient-level data”

Patient journey mapping works to identify and understand the details of all patient touchpoints within a specific healthcare experience. It illustrates the process patients go through to receive care, complete a treatment plan, and/or reach a desired outcome. When patient journey maps are done correctly, they efficiently identify pain points, discover opportunities and re-align treatment and care approaches across the healthcare ecosystem. Together, Real Chemistry and WhizAI will build a robust patient journey software solution specific to the demanding needs and complexities of the regulated healthcare environment. This will help clients better understand how best to market to identified audiences in ways that are most authentic to the patient experience.

Read More about AiThority Interview: AiThority Interview with Bret Greenstein, Partner, Data & AI at PwC

“At Real Chemistry, we believe that healthcare is personal and that every patient’s story is unique,” said Dan Fisher, Practice Leader for IPM.ai, part of Real Chemistry. “We have spent the last five years perfecting the science of finding patients with AI and machine learning. Now we are bringing focus to the detailed and varying patient journeys across therapeutic areas. By coupling Real Chemistry’s robust analytics engine with WhizAI’s generative AI-powered visualization platform, we are democratizing analytics for life science customers. Patient journey mapping isn’t new, but this dynamic platform will allow users to ask questions about specific disease states and, through generative AI and analytics, have their questions answered with best-in-class data and insights, enabling better patient outcomes.”

“Real Chemistry is a leader in uncovering insights for complex diseases and mapping treatments by using vast amounts of patient-level data,” says Bijal Karande, Vice President, Partnerships, WhizAI. “Together, our newly introduced solution leverages generative AI to streamline the process for clients to access precise, context-based, and real-time insights. This enables more informed decision-making and expedites the determination of optimal next steps for improved patient outcomes.”

 Latest AiThority Interview Insights : AiThority Interview with Ganesh Shankar, CEO and Co-founder at Responsive (formerly RFPIO)

 [To share your insights with us, please write to sghosh@martechseries.com]